aService de Néphrologie-Immunologie Clinique, CHU Tours
bEA4245 François-Rabelais University, Tours
cFCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, Nancy, France
dPole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique
eDivision of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
fDepartment of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
gService of Nephrology and Hypertension, University Hospital (CHUV), Lausanne, Switzerland
hDepartment of Nephrology, Antwerp University Hospital
iAntwerp University, Antwerp, Belgium
jDepartment of Nephrology, Medical University of Vienna, Vienna, Austria
kCNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy
lManhes Hospital and FCRIN INI-CRCTC, Manhes
mINSERM, Centre d’Investigations Cliniques Plurithématique 1433, UMR 1116, Université de Lorraine, CHU de Nancy, Nancy, France
Correspondence to Jean-Michel Halimi, Service de Néphrologie-Immunologie Clinique, Hôpital Bretonneau, CHU Tours, Tours, France. Tel: +33 247473746; fax: +33 247473802; e-mail: [email protected]
*This article has been co-published in Nephrology Dialysis Transplantation.
Received 4 August, 2017
Accepted 5 September, 2017